SMi's 19th Annual Pain Therapeutics Conference

SMi's 19th Annual Pain Therapeutics Conference is organized by SMi Group Ltd and will be held from May 13 - 14, 2019 at Copthorne Tara Hotel London Kensington, London, England, United Kingdom.

Who Should Attend:
Amgen; Aptinyx; Arthritis Research UK; Asahi Kasei Corporation; AstraZeneca; Bayer AG; BenevolentAI; Cellectricon; Centrexion Therapeutics Corp.; Chdr; Clermont Universit; Danish Headache Centre; Drug Discovery Today; Eli Lilly & Co; Eli Lilly and Company; Eupraxia Pharmaceuticals; Flexion Therapeutics; Gr³nenthal Group; Grunenthal Gmb H; Innopain; Ipsen; Ipsen Biopharma; Iptechex Pharmalicensing; Lotus Clinical Research, Llc; MD Biosciences; Medherant Limited; Merck Research Laboratories; Metys Pharmaceuticals; MHRA; MSD; Mundipharma International; Mundipharma International Ltd; Novartis Pharmaceuticals; Orion Pharma; Orion Pharma (UK) Ltd; Pharmaleads; Pierre Fabre France; Premier Research; Premier Research Gemany Ltd.; Premier Research Group; Semnur Pharmaceuticals; THE ANN HAYES CONSULTANCY; Viromed.

Conference Overview:
Proudly sponsored by: Lotus Clinical Research and MD Biosciences

The global opioids market size was valued at $22.96bn USD in 2016 and is projected to expand at a CAGR of 4.8% between 2018 and 2025. Rising prevalence of diseases that cause chronic pain, such as cancer, lower back pain, post-surgical pain, arthritis, and fibromyalgia, is driving growth.

Join Europe's leading Pain Therapeutics Conference, to explore the cutting-edge research of novel therapeutic targets in the pipeline of leading pharmaceutical companies and to discuss solutions for the challenges of clinical trial design and conduct.

The 19th annual conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, atypical opioids, migraine treatments, such as Lasmiditan and Aimovig, novel discoveries in opioid-free analgesia and the future forecast for pain therapeutics – industry leaders will uncover the latest advancements in the field. Furthermore, policy experts will provide an essential regulatory perspective for this year’s agenda, providing an exciting and comprehensive insight into the pain therapeutics market.

New case studies and regulatory perspectives will bring together the challenges and successes of both pre-clinical and clinical development to equip you with the necessary knowledge to advance the pain therapeutic industry.

Time: 8:30 am to 5:35 pm

Additional details will be posted as soon as they are available.